المؤلفون: Marie Daude, Monica Dinulescu, Jean‐Michel Nguyen, Hervé Maillard, Florence Le Duff, Laurent Machet, Marie Beylot‐Barry, Delphine Legoupil, Ewa Wierzbicka‐Hainaut, Christophe Bedane, Marie Thérèse Leccia, Sébastien Debarbieux, Nicolas Meyer, Sandrine Monestier, Guido Bens, Marc G. Denis, Celine Bossard, Beatrice Vergier, Amir Khammari, Brigitte Dréno

المصدر: Journal of the European Academy of Dermatology and Venereology.

مصطلحات موضوعية: Infectious Diseases, Dermatology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::bd4a448c570081b3153b8f84a2375c38Test
https://doi.org/10.1111/jdv.19141Test

المؤلفون: Sergey I. Nikolaev, Nicole Basset-Seguin, Lukas Flatz, Nicolas Dumaz, Frederic J. de Sauvage, Jerome Lambert, Florian Herms, Philippe Saiag, Caroline Robert, Caroline Dutriaux, Nicolas Meyer, Laurent Mortier, Sandrine Monestier, Florent Grange, Max Mendez-Lopez, Andrej Besse, Ariel Savina, Fanny Bouquet, Samia Mourah, Maxime Battistella, Nadem Soufir, Antonio Alberti, Marc Delord, Amir Khammari, Brigitte Dreno, Nicolas Poulalhon, Hayley J. Sharpe, Fatemeh Rajabi, Ismael Padioleau, Meriem Ighilahriz, Oltin T. Pop, Andrey A. Yurchenko

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::351f6102c14b7c4e17ca3b39ea656edfTest
https://doi.org/10.1158/1078-0432.22487462.v1Test

المؤلفون: Sergey I. Nikolaev, Nicole Basset-Seguin, Lukas Flatz, Nicolas Dumaz, Frederic J. de Sauvage, Jerome Lambert, Florian Herms, Philippe Saiag, Caroline Robert, Caroline Dutriaux, Nicolas Meyer, Laurent Mortier, Sandrine Monestier, Florent Grange, Max Mendez-Lopez, Andrej Besse, Ariel Savina, Fanny Bouquet, Samia Mourah, Maxime Battistella, Nadem Soufir, Antonio Alberti, Marc Delord, Amir Khammari, Brigitte Dreno, Nicolas Poulalhon, Hayley J. Sharpe, Fatemeh Rajabi, Ismael Padioleau, Meriem Ighilahriz, Oltin T. Pop, Andrey A. Yurchenko

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a2b97d45e46bb583500481210757562Test
https://doi.org/10.1158/1078-0432.c.6532523.v1Test

المؤلفون: Andrey A. Yurchenko, Oltin T. Pop, Meriem Ighilahriz, Ismael Padioleau, Fatemeh Rajabi, Hayley J. Sharpe, Nicolas Poulalhon, Brigitte Dreno, Amir Khammari, Marc Delord, Antonio Alberti, Nadem Soufir, Maxime Battistella, Samia Mourah, Fanny Bouquet, Ariel Savina, Andrej Besse, Max Mendez-Lopez, Florent Grange, Sandrine Monestier, Laurent Mortier, Nicolas Meyer, Caroline Dutriaux, Caroline Robert, Philippe Saiag, Florian Herms, Jerome Lambert, Frederic J. de Sauvage, Nicolas Dumaz, Lukas Flatz, Nicole Basset-Seguin, Sergey I. Nikolaev

المساهمون: Pecqueret, Valérie, Biomarqueurs prédictifs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse (U981), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Prédicteurs moléculaires et nouvelles cibles en oncologie (PMNCO), Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Brustzentrum Kantonsspital St. Gallen, Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), The Babraham Institute [Cambridge, UK], Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes-Angers (CRCI2NA ), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), Centre d’Investigation Clinique de Nantes (CIC Nantes), Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre hospitalier universitaire de Nantes (CHU Nantes), Immunology and New Concepts in ImmunoTherapy (INCIT), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Centre hospitalier universitaire de Nantes (CHU Nantes), Université Paris Diderot, Sorbonne Paris Cité, Paris, France, Université Paris Diderot - Paris 7 (UPD7), Institut de Recherche Saint-Louis - Hématologie Immunologie Oncologie (Département de recherche de l’UFR de médecine, ex- Institut Universitaire Hématologie-IUH) (IRSL), Université Paris Cité (UPCité), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut ROCHE [Boulogne-Billancourt], Roche S.A.S, Centre Hospitalier Universitaire de Reims (CHU Reims), Hôpital de la Timone [CHU - APHM] (TIMONE), Equipe 3 - Facteurs de persistance des cellules leucémique - (INSERM U837), Institut pour la Recherche sur le Cancer de Lille (U837 INSERM - IRCL), Institut pour la recherche sur le cancer de Lille [Lille] (IRCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut pour la recherche sur le cancer de Lille [Lille] (IRCL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), CHU Bordeaux [Bordeaux], Institut Gustave Roussy (IGR), Oncologie dermatologique, Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Hôpital Ambroise Paré [AP-HP], Service de Dermatologie [AP-HP Hôpital Saint-Louis], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Genentech, Inc., Genentech, Inc. [San Francisco]

المصدر: Clinical Cancer Research
Clinical Cancer Research, 2022, pp.clincanres.3764.2021. ⟨10.1158/1078-0432.CCR-21-3764⟩

مصطلحات موضوعية: Cancer Research, Skin Neoplasms, animal structures, integumentary system, Pyridines, [SDV]Life Sciences [q-bio], fungi, Antineoplastic Agents, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV] Life Sciences [q-bio], [SDV.CAN] Life Sciences [q-bio]/Cancer, Oncology, Carcinoma, Basal Cell, Humans, Anilides, Hedgehog Proteins, Cerebellar Neoplasms

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1499e614bc9925511cb91b87a6471f26Test
https://doi.org/10.1158/1078-0432.ccr-21-3764Test

المؤلفون: Stéphane Dalle, Patrick Combemale, Yannick Le Corre, Caroline Dutriaux, E. Varey, Nathalie Beneton, Thomas Jouary, Caroline Robert, Henri Montaudié, Jean Philippe Arnault, Sandrine Monestier, Marie Thérèse Leccia, Sandrine Mansard, Laurent Mortier, Amir Khammari, Anne-Bénédicte Duval Modeste, François Skowron, Nicolas Meyer, Brigitte Dréno, Nabahet Ameur, Bernard Guillot, Philippe Saiag, E. Hainaut, Sophie Dalac-Rat

المساهمون: Service de dermatologie, vénéreologie et cancérologie cutanée [Hôpital de la Timone - APHM], Hôpital de la Timone [CHU - APHM] (TIMONE)-Assistance Publique - Hôpitaux de Marseille (APHM)-Aix Marseille Université (AMU), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 (ONCO-THAI), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille, CHU Bordeaux [Bordeaux], Service de Dermatologie (CHU de Dijon), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire [Grenoble] (CHU), CHU Clermont-Ferrand, Hôpital Archet 2 [Nice] (CHU), Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay, Hôpital Ambroise Paré [AP-HP], Centre Léon Bérard [Lyon], CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Charles Nicolle [Rouen], Centre Hospitalier Le Mans (CH Le Mans), Centre hospitalier universitaire de Poitiers (CHU Poitiers), Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR), Service de dermatologie [CHU d'Amiens-Picardie], CHU Amiens-Picardie, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Centre hospitalier de Pau, Centre d’Investigation Clinique de Nantes (CIC Nantes), Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre hospitalier universitaire de Nantes (CHU Nantes), Amgen Bristol-Myers Squibb, BMS Pfizer Novartis Roche AbbVie Les Laboratories Pierre Fabre LEO Pharma Research Foundation, Sandrine Monestier has received consultant fees from BMS and Roche, support for travel/congress from BMS, Roche, GSK and MSD, and has participated as an investigator on clinical trials for BMS, Roche‐ Genentech, GSK, Amgen, Novartis, MSD, Merck‐Serono and Astra Zeneca. Stéphane Dalle has received congress invitation and fees coverage from BMS, Pierre Fabre and MSD, translational study grant to institution from BMS and MSD. Laurent Mortier received support to travel to medical congresses from BMS, MSD, Roche and Novartis. Caroline Dutriaux has been a member of advisory boards and received consultancy fees from BMS, MSD, Pierre Fabre and Novartis. Sophie Dalac‐Rat has received honoraria, provided consultancy and been on advisory committees for BMS, MSD, Novartis and Sun pharma. Nicolas Meyer has received honoraria from Sun Pharma, Roche, Novartis and Pierre Fabre, research funding from BMS, MSD, provided consultancy to BMS, MSD, Roche, Novartis and Pierre Fabre, been on advisory committees for Amgen, Incyte, BMS, MSD, Roche, Novartis and Pierre Fabre. Sandrine Mansard has worked on advisory boards for BMS and Novartis, has received congress and travel fees from BMS and Pierre Fabre. Henri Montaudié has worked on advisory boards for BMS, MSD, Pierre Fabre and Novartis, provided consultancy to MSD and Pierre Fabre, received honoraria from BMS, MSD, Pierre Fabre and Novartis, received research funding from BMS and Leo Pharma. Philippe Saiag has received personal fees from Amgen, Bristol‐Myers Squibb, MSD, Merck‐Serono, Pfizer, Roche‐Genentech, Pierre Fabre and Novartis, received nonfinancial support from Bristol‐Myers Squibb, MSD, Roche‐Genentech and Novartis, received a funding grant from Roche‐Genentech. Patrick Combemale has worked on advisory committees for Roche, Pierre Fabre and AstraZenecca. Ewa Hainaut has been a speaker for BMS, Novartis and Sanofi, worked on advisory boards for Novartis and Sanofi, received research funding from Abbvie. Caroline Robert has received consultancy fees from BMS, MSD, Roche, Novartis, Sanofi, Pierre Fabre and Amgen. Yannick Le Corre has provided consultancy to BMS, MSD and Novartis, worked on advisory boards for BMS, MSD, Novartis and Pierre Fabre, received congress invitation from BMS, MSD and Novartis, has received honoraria from BMS. Nabahet Ameur is employee of Bristol‐Myers‐Squibb. Brigitte Dréno has received research funding from Amgen, BMS, Novartis and Roche, provided consultancy to BMS and Roche, worked on advisory boards for BMS, Roche and Pierre Fabre. Jean Philippe Arnault has been a speaker for BMS. Marie Thérèse Leccia, Bernard Guillot, François Skowron, Anne‐Bénédicte Duval Modeste, Nathalie Bénéton, Thomas Jouary, Emilie Varey, and Amir Khammari have no conflicts of interest to declare., Aix Marseille Université (AMU)-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Rouen, Normandie Université (NU)-Normandie Université (NU), HAL UVSQ, Équipe, Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: International Journal of Cancer
International Journal of Cancer, Wiley, 2021, 148 (11), pp.2789-2798. ⟨10.1002/ijc.33467⟩
International Journal of Cancer, 2021, 148 (11), pp.2789-2798. ⟨10.1002/ijc.33467⟩

مصطلحات موضوعية: Male, advanced melanoma, safety, Cancer Research, medicine.medical_specialty, real-world, Databases, Factual, effectiveness, [SDV.CAN]Life Sciences [q-bio]/Cancer, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, medicine, Humans, In patient, Adverse effect, Melanoma, Advanced melanoma, Aged, Retrospective Studies, Aged, 80 and over, nivolumab, business.industry, Incidence (epidemiology), Retrospective cohort study, Middle Aged, Survival Analysis, 3. Good health, Clinical trial, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Observational study, France, Nivolumab, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14f417395eb026535a482cd67ec9bacbTest
https://hal.archives-ouvertes.fr/hal-03287366Test

المؤلفون: Michel Ticchioni, Jean-David Bouaziz, Jean-Philippe Lacour, Pascal Reygagne, Marie-Aleth Richard, Sandrine Monestier, Florence Le Duff, Henri Montaudié, Thierry Passeron, Olivier Dereure, Manuelle Viguier, Eric Fontas

المساهمون: Centre Hospitalier Universitaire de Reims (CHU Reims), Immuno-Régulation dans les Maladies Auto-Immunes Inflammatoires et le Cancer - EA 7509 (IRMAIC), Université de Reims Champagne-Ardenne (URCA), Centre Hospitalier Universitaire de Nice (CHU Nice), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Pathogénèse et contrôle des infections chroniques (PCCI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Montpellier (CHU Montpellier )-Université de Montpellier (UM), Assistance Publique - Hôpitaux de Marseille (APHM), Hôpital de la Timone [CHU - APHM] (TIMONE), Centre méditerranéen de médecine moléculaire (C3M), Université Nice Sophia Antipolis (... - 2019) (UNS), COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-COMUE Université Côte d'Azur (2015-2019) (COMUE UCA)-Université Côte d'Azur (UCA)-Institut National de la Santé et de la Recherche Médicale (INSERM)

المصدر: Journal of Investigative Dermatology
Journal of Investigative Dermatology, Nature Publishing Group, 2021, 141 (4), pp.933-936.e6. ⟨10.1016/j.jid.2020.08.015⟩

مصطلحات موضوعية: Moderate to severe, medicine.medical_specialty, Cell, Placebo-controlled study, Dermatology, Biochemistry, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, T-regulatory cell, Internal medicine, medicine, Molecular Biology, ComputingMilieux_MISCELLANEOUS, 030304 developmental biology, 0303 health sciences, business.industry, Low dose, Cell Biology, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, Alopecia areata, medicine.disease, 3. Good health, medicine.anatomical_structure, 030220 oncology & carcinogenesis, business, [SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04904421ecde81e777cd85810e56fab3Test
https://hal.univ-reims.fr/hal-03425030Test

المؤلفون: Guido Bens, Sandrine Mansard, Elisa Funck-Brentano, Sandrine Monestier, Géraldine Jeudy, Mathurin Fumery, Groupe de cancérologie cutanée de la Société française de dermatologie, Laurent Mortier, Jean-Philippe Arnault, Ali Dadban, Anne-Bénédicte Duval-Modeste, Catherine Lok, Guillaume Chaby, Laurent Machet, Chloe Vuillamy

المصدر: Annales de Dermatologie et de Vénéréologie - FMC. 1:A82

مصطلحات موضوعية: Ocean Engineering, Safety, Risk, Reliability and Quality

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::fef8a99694f51eae9ba75c03a004db8eTest
https://doi.org/10.1016/j.fander.2021.09.482Test

المؤلفون: Caroline Gaudy-Marqueste, Sandrine Monestier, Nausicaa Malissen, Sarah Devey, Marie-Aleth Richard, Jean-Jacques Grob, Florent Amatore, L. Troin, Clémence Tabelé

المصدر: Journal of the European Academy of Dermatology and Venereology. 34

مصطلحات موضوعية: medicine.medical_specialty, Infectious Diseases, business.industry, medicine, Alternative medicine, MEDLINE, Dermatology, Skin cancer, medicine.disease, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c602e94106bdba32ace038bd50fad9b2Test
https://doi.org/10.1111/jdv.16142Test

المؤلفون: Céleste Lebbé, Martine Bagot, Nicolas Meyer, Pierre Vabres, Jean-Jacques Grob, Caroline Dutriaux, N. Poulalhon, Christine Mateus, Nicole Basset-Seguin, Florian Herms, Laurent Mortier, Jérôme Lambert, Géraldine Jeudy, Bernard Guillot, Luc Haudebourg, Sandrine Monestier, Sophie Dalac, Sorilla Prey, Caroline Robert

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37(34)

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Time Factors, Pyridines, Locally advanced, Vismodegib, Antineoplastic Agents, Gastroenterology, Drug Administration Schedule, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, Carcinoma, medicine, Humans, Basal cell carcinoma, Anilides, Progression-free survival, Aged, Retrospective Studies, Aged, 80 and over, business.industry, Retrospective cohort study, Middle Aged, medicine.disease, Hedgehog signaling pathway, Progression-Free Survival, Discontinuation, Oncology, Carcinoma, Basal Cell, 030220 oncology & carcinogenesis, Retreatment, Disease Progression, Female, France, Neoplasm Recurrence, Local, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff5c04dd61727395dd8fe7ad7660fcb9Test
https://pubmed.ncbi.nlm.nih.gov/31609670Test

المؤلفون: A.-S. Dussouil, Anderson Loundou, L. Troin, N. Malissen, Jean-Jacques Grob, Romain Carron, Sandrine Monestier, J. Regis, Caroline Gaudy-Marqueste, Marie Aleth Richard, Stéphanie Mallet

المصدر: European Journal of Cancer. 84:44-54

مصطلحات موضوعية: Male, Proto-Oncogene Proteins B-raf, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Time Factors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Antineoplastic Agents, Ipilimumab, Kaplan-Meier Estimate, Radiosurgery, Antibodies, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Internal medicine, medicine, Humans, Molecular Targeted Therapy, Melanoma, Protein Kinase Inhibitors, Proportional Hazards Models, Retrospective Studies, Brain Neoplasms, Proportional hazards model, business.industry, Retrospective cohort study, Immunotherapy, Middle Aged, MAP Kinase Kinase Kinases, medicine.disease, Surgery, Treatment Outcome, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Multivariate Analysis, Mutation, Female, business, 030217 neurology & neurosurgery, Brain metastasis, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b2092872a172b1e9efcd0e43a9316eTest
https://doi.org/10.1016/j.ejca.2017.07.017Test